Florence Joly

5.1k citations
56 papers · 1.4k indexed · 1 hit paper · h-index 15
Topics
Ovarian cancer diagnosis and treatment (26 papers)PARP inhibition in cancer therapy (13 papers)Intraperitoneal and Appendiceal Malignancies (9 papers)
Partner nations
FranceLuxembourgItaly

In The Last Decade

Florence Joly

48 papers receiving 1.4k citations

Hit Papers

Pegylated Liposomal Doxorubicin and Carboplatin Compared ...20102026201520202010100200300400

Peers

Florence Joly
Comparison fields: 5 of 90
  • Reproductive Medicine 534
  • Oncology 483
  • Surgery 381
  • Obstetrics and Gynecology 245
  • Molecular Biology 243
Replace Daichi Maeda with:
Daichi Maeda Japan
E. Dreher Switzerland
Francesca Megiorni Italy
James P. LaPolla United States
Matteo Morotti Italy
Esther Elishaev United States
Yu Du China
Adrian A. Suarez United States
Quancai Cui China
Kohkichi Hata Japan
Florence Joly relative to Daichi Maeda Japan Daichi Maeda's profile →
Citations per field
00.5×
Daichi Maeda · 1×
Citations per year

Countries citing papers authored by Florence Joly

Since Specialization
Citations

This map shows the geographic impact of Florence Joly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Florence Joly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Florence Joly more than expected).

Fields of papers citing papers by Florence Joly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Florence Joly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Florence Joly. The network helps show where Florence Joly may publish in the future.

Co-authorship network of co-authors of Florence Joly

This figure shows the co-authorship network connecting the top 25 collaborators of Florence Joly. A scholar is included among the top collaborators of Florence Joly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Florence Joly. Florence Joly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 0
4 14
5 6
6 0
7 0
8 0
9 13
10 7
11 3
12 150
13 5
14 75
15
Pegylated Liposomal Doxorubicin and Carboplatin Compared With Paclitaxel and Carboplatin for Patients With Platinum-Sensitive Ovarian Cancer in Late Relapsebreakdown →
410
16 69
17 9
18 24
19 22
20 18

About Florence Joly

Florence Joly is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Oncology, having authored 56 papers that have together received 1.4k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (26 papers), PARP inhibition in cancer therapy (13 papers) and Intraperitoneal and Appendiceal Malignancies (9 papers). The work is most often cited by research in Reproductive Medicine (534 citations), Obstetrics and Gynecology (245 citations) and Oncology (483 citations). Florence Joly has collaborated with scholars based in France, Luxembourg and Italy. Frequent co-authors include Andreas du Bois, Éric Pujade-Lauraine, Gunnar B. Kristensen, Jalid Sehouli, Christian Jackisch, Alain Lortholary, Annamaria Ferrero, Ignace Vergote, Chris Brown and Birgit Volgger. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026